Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darbepoetin Alfa Dosing Strategies in CKD Anemia
NCT01652872Phase 3Completed
- Sponsor
- Amgen
- Start
- Jul 2012
- Primary completion
- Oct 2017
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 2
01
Overview
A Phase 3 trial of darbepoetin alfa in anemia, sponsored by Amgen. Started Jul 2012; status: completed.
02
Drugs
darbepoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT01652872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01652872.